Metadoxime - Hepatobiliary agent
Drug Name:
Metadoxime - Hepatobiliary agent
List Of Brands:
Indication Type Description:
Pharmacology/ Pharmacokinetics
Drug Interaction:
Not reported
Indication:
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Metadoxime 24-10-2003
For Hepatic Relaxant
Alcoholic fatty liver
Adverse Reaction:
Not reported
Contra-Indications:
Hypersensitivity Special precautions- In patients with parkinson taking levodopa, caution should be excercised as metadoxine may antagonise the drug.
Dosages/ Overdosage Etc:
Acute & chronic liver diseases
Dosage-
300-1000mg daily
Pharmacology/ Pharmacokinetics:
Pharmacology- Metadoxine is an ion-pair consisting of pyridoxine with pyrolidone carboxylate> Some researches have suggested that the effect of metadoxine is loely attributed to the biotransformation of alcohol into less harmful compounds, mainly rapidly eliminated higherr ketones resulting in more rapid lowering of alcohol and acetaldehyde concentration in blood and tissues. In animal pharmacology data suggest that metadoxine may have direct effects on the central nervous system CNS that are independent of any effect on alcohol metabolism Clinical efficay- In patients with alcoholic fatty liver metadoxime accelrates the normalization of liver function tests and the ultrasono-graphic changes even in those who do not completely abstain from alcohol intake
Interaction with Food:
Not reported
Pregnancy and lactation:
Not reported